Search Results 1291-1300 of 16307 for transexamic

  1. Lurbinectedin (intravenous route) - Side effects & uses - Mayo Clinic

    Lurbinectedin injection is used to treat metastatic (cancer that has already spread) small cell lung cancer (SCLC) in patients who have received other cancer ...

  2. Surgery - Clinical trials

    This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or cetuximab and ...

  3. Sulbactam and durlobactam (intravenous route) - Side effects & uses - Mayo Clinic

    Description. Sulbactam and durlobactam combination injection is used to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial ...

  4. Mayo Clinic

    cc-female-petting-dog_mobile · There's still time · About Mayo Clinic · Medical Professionals · Businesses · Students · Researchers · International Patients.

  5. Phenobarbital (intravenous route) - Mayo Clinic

    Phenobarbital injection is used to treat seizures in babies. Phenobarbital belongs to the group of medicines called barbiturates. Barbiturates act in the ...

  6. Primary Care in Florida - Doctors - Mayo Clinic

    Learn about primary care services, including family medicine and community internal medicine at several locations and how to find a doctor and make an ...

  7. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  8. Clinical trials - Gastroenterology and Hepatology

    Mayo Clinic's Division of Gastroenterology and Hepatology offers treatment and specialty care for people with a wide range of rare and common digestive ...

  9. Surgery - Doctors - Mayo Clinic

    Mayo Clinic Surgery offers deep expertise and a wide range of surgical care to tens of thousands of people each year.

  10. A Trial To Evaluate The Safety Of Long Term Treatment With Nintedanib In Patients With Scleroderma Related Lung Fibrosis - Mayo Clinic

    The main objective is to assess long term safety of treatment with oral nintedanib in patients with Systemic Sclerosis associated Interstitial Lung Disease (SSc ...